J. Goldman & Co LP - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 88 filers reported holding RAPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 1.4%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$224,370
-74.2%
13,500
-65.8%
0.01%
-80.0%
Q1 2022$868,000
-53.7%
39,491
-22.7%
0.04%
-61.2%
Q4 2021$1,875,00051,0560.10%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$44,551,92129.58%
GREAT POINT PARTNERS LLC 1,458,070$24,233,1234.41%
Euclidean Capital LLC 1,315,798$21,868,5622.39%
Trustees of Columbia University in the City of New York 73,383$1,219,6252.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 805,828$13,392,8611.54%
Perceptive Advisors 1,920,658$31,921,3361.06%
Deep Track Capital, LP 1,500,000$24,930,0000.96%
Cheyne Capital Management (UK) LLP 20,000$332,4000.96%
Alphabet Inc. 540,270$8,979,2870.58%
BRAIDWELL LP 1,082,512$17,991,3490.57%
View complete list of RAPT THERAPEUTICS INC shareholders